An experimental compound shows promising signs in mouse models of halting the progression of primary sclerosing cholangitis (PSC), a potentially fatal liver condition that affects about one in 100,000 children in the U.S.
Read More| Research and Training Details | |
|---|---|
| Faculty | 38 |
| Joint Appointment Faculty | 2 |
| Research Fellows and Post Docs | 10 |
| Research Graduate Students | 13 |
| Total Annual Grant Award Dollars | $9,185,873 |
| Total Annual Industry Award Dollars | $100,997 |
| Total Publications | 142 |
| Clinical Activities and Training | |
|---|---|
| Staff Physicians | 2 |
| Clinical Fellows | 13 |
| Inpatient Encounters | 9,528 |
| Outpatient Encounters | 21,923 |